APA (7th ed.) Citation

Lodise, T., Colman, S., Stein, D. S., Fitts, D., Goldberg, L., Alexander, E., . . . Schranz, J. (2020). Post Hoc Assessment of Time to Clinical Response Among Adults Hospitalized with Community-Acquired Bacterial Pneumonia Who Received Either Lefamulin or Moxifloxacin in 2 Phase III Randomized, Double-Blind, Double-Dummy Clinical Trials. Open Forum Infectious Diseases, 7(5), 1. https://doi.org/10.1093/ofid/ofaa145

Chicago Style (17th ed.) Citation

Lodise, Thomas, Sam Colman, Daniel S. Stein, David Fitts, Lisa Goldberg, Elizabeth Alexander, Patrick J. Scoble, and Jennifer Schranz. "Post Hoc Assessment of Time to Clinical Response Among Adults Hospitalized with Community-Acquired Bacterial Pneumonia Who Received Either Lefamulin or Moxifloxacin in 2 Phase III Randomized, Double-Blind, Double-Dummy Clinical Trials." Open Forum Infectious Diseases 7, no. 5 (2020): 1. https://doi.org/10.1093/ofid/ofaa145.

MLA (9th ed.) Citation

Lodise, Thomas, et al. "Post Hoc Assessment of Time to Clinical Response Among Adults Hospitalized with Community-Acquired Bacterial Pneumonia Who Received Either Lefamulin or Moxifloxacin in 2 Phase III Randomized, Double-Blind, Double-Dummy Clinical Trials." Open Forum Infectious Diseases, vol. 7, no. 5, 2020, p. 1, https://doi.org/10.1093/ofid/ofaa145.